BioGeneric Pharma S.A.E (BGP) is an international company whose principal activities are the development, production, and marketing of biopharmaceutical products. BGP is a new “State of the Art” biopharmaceutical manufacturing facility in the 10th of Ramadan Industrial City, Egypt.
| Website | https://www.biogenericpharma.com |
| Revenue | $6.7 million |
| Employees | 106 (87 on RocketReach) |
| Founded | 2005 |
| Industry | Biotechnology Research |
| Keywords | Biopharmaceutical Products, Biopharmaceutical Manufacturing, Drug Development, Pharmaceutical Production, Biologics Manufacturing, Generic Drugs, Biosimilars, Drug Manufacturing, Pharmaceutical Development, Health, Biotechnology, Drug Production, Healthcare, Clinical Trials, Fda, Research And Development, Regulatory Affairs, Quality Control |
| Competitors | Roche, Novartis, AbbVie, GSK, Amgen, Boehringer Ingelheim, Teva Pharmaceuticals, Sandoz, Lilly India, Mylan Belgium +45 more (view full list) |
Looking for a particular BGP employee's phone or email?
The BGP annual revenue was $6.7 million in 2026.
Sherif Diab is the Business Development Director of BGP.
87 people are employed at BGP.